Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AtriCure, Inc.

Market Cap 1.44B 1.25B 1.15B 1.08B 2.01B 138B 2.06B 13.73B 5.32B 66.4B 5.4B 5.28B 231B P/E Ratio 2026 *
619x
P/E Ratio 2027 * 83.6x
Enterprise Value 1.28B 1.11B 1.03B 961M 1.8B 123B 1.83B 12.24B 4.74B 59.2B 4.82B 4.71B 206B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.78x
Free-Float
96.14%
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week+5.65%
Current month+3.47%
1 month+7.27%
3 months-3.06%
6 months-32.44%
Current year-27.63%
1 week 26.62
Extreme 26.62
28.91
1 month 25.36
Extreme 25.36
29.45
Current year 25.36
Extreme 25.36
43.18
1 year 25.36
Extreme 25.36
43.18
3 years 18.94
Extreme 18.94
59.61
5 years 18.94
Extreme 18.94
89.18
10 years 13.45
Extreme 13.45
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 54 01/03/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap.
05-20Sell

Director

-3,000 0.0059%
05-18Free

Director

6,144 0.0121%
05-18Free

Director

6,144 0.0121%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%+5.65%-11.44%-39.38% 1.44B
-1.81%-3.34%-35.49%-13.19% 156B
-0.17%-1.84%-9.40%-4.88% 103B
-0.29%+2.01%-4.90%+56.47% 54.77B
+3.00%-0.04%+54.23%+54.37% 53.52B
-1.12%-3.63%-16.50%-41.90% 40.6B
-2.22%+7.94% - - 31.4B
-0.88%+2.26%-10.07%-41.29% 29.04B
-0.43%+4.70%+46.41%-7.86% 23.34B
-2.85%-3.36%-17.02%-0.74% 20.81B
Average -0.63%+1.88%-0.47%-4.27% 51.42B
Weighted average by Cap. -0.75%+0.40%-8.55%+0.59%

Financials

2026 *2027 *
Net sales 605M 525M 484M 453M 847M 57.92B 865M 5.77B 2.23B 27.92B 2.27B 2.22B 97.08B 678M 589M 543M 509M 950M 64.96B 970M 6.47B 2.51B 31.31B 2.55B 2.49B 109B
Net income 2.66M 2.31M 2.13M 1.99M 3.73M 255M 3.8M 25.38M 9.83M 123M 9.99M 9.77M 427M 17.48M 15.17M 13.99M 13.1M 24.48M 1.67B 24.99M 167M 64.59M 807M 65.63M 64.22M 2.81B
Net Debt -156M -135M -125M -117M -218M -14.94B -223M -1.49B -576M -7.2B -586M -573M -25.03B -232M -202M -186M -174M -325M -22.24B -332M -2.22B -858M -10.72B -872M -853M -37.27B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
12/06/26 28.66 $ +0.86% 111,590
11/06/26 28.41 $ +3.27% 1,105,142
10/06/26 27.51 $ +0.77% 703,862
09/06/26 27.30 $ +1.43% 607,249
08/06/26 26.92 $ -0.68% 559,543
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
28.41USD
Average target price
47.00USD
Spread / Average Target
+65.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!